Science
Fziomed’s adhesion prevention products are unlike any other in the marketplace. Since 1996, Fziomed has been at the forefront as an early pioneer in the field of adhesion prevention. Our proprietary dual-polymer technology offers clinical advantages that go beyond simple hyaluronic acid (HA)-based products and other gel, film, and sheet technologies.
ProprietaryOur proprietary combination of two safe and extensively studied synthetic polymers—carboxymethylcellulose (CMC) and polyethylene oxide (PEO)—results in adhesion barriers offering a unique mode of action and combination of benefits.
Our synthetic polymer gels contain no pharmaceutical agents and no materials of human, animal, or bacterial origin. Clinical study data and more than two decades of commercial experience have demonstrated the safety and biocompatibility of our products.
The CMC in our gel allows for adherence to tissues and/or neural elements in a variety of anatomical locations and clinical environments. Our products are designed to stay in place, protecting the surgical site throughout the period of adhesion formation.
The PEO in our gel provides a unique protective function that disrupts the deposition of fibrin-building proteins and inflammatory cytokines. As proteins come in contact with PEO, they dissipate, preventing fibrin bridge (adhesion) formation, limiting the effects of inflammatory cytokines and reducing painful inflammation during the healing process.
Our proprietary dual-polymer technology is tailored to meet the needs of specific clinical applications with distinct viscosity, elasticity, and absorption characteristics.
Fziomed products are provided sterile and ready to use – no mixing required – and conveniently stored at room temperature.
Our adhesion barrier gels are naturally absorbed over time, in tune with the body’s healing process. Residence time is optimized for specific surgical applications and the gel remains at the site of application for up to 30 days. Decades of use have demonstrated its safety and its clinically meaningful benefit.
Contact us for additional information or to inquire about product availability in your country.
Fziomed, Inc.
231 Bonetti Drive
San Luis Obispo, CA 93401
USA
Phone: +1 (805) 546-0610
Fax: +1 (805) 546-0571
Email: [email protected]
Fziomed products are not currently available in the United States.
The following trademarks are owned by Fziomed, Inc. and registered in the United States and certain foreign jurisdictions: FZIOMED®, OXIPLEX®, OXIPLEX/SP®, DYNAVISC®, INTERPOSE®, INTERCOAT®, OXIPLEX/AP®, and OXIPLEX/IU®.
Website design RainCastle Communications.
Last update: Feb. 25, 2025
Distributor Login